Hungary

CJEU, Enforcement, European Union, Hungary, Injunction

(Danubia Legal)/

The injunction gap is a frequently discussed characteristic of those European jurisdictions, Hungary being one such country, whose  patent litigation systems are bifurcated. In a preliminary injunction proceeding in Hungary the court does not assess the validity of the patent in suit, at least not simply at the level of arguments, although decisions on invalidity…

European Union, Hungary, Patents, SPC

(Danubia Legal) and (Danubia Patent and Law Office)/

Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. The Hungarian court which regularly deals…

European Union, Hungary, Unitary Patent, UPC

/ /3 Comments

The Hungarian Constitutional Court has ruled that the Unified Patent Court Agreement can’t be ratified, as no appropriate mechanism for the ratification is available. According to a report by Bristows, the Hungarian Minister of Justice, acting on behalf of the government, filed a motion (No. X / 01514/2017) on 18 July 2017, requesting the Court’s opinion…

Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, European Union, Extent of Protection, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Pharma, Poland, Portugal, Romania, Scope of protection, Slovakia, Slovenia, Spain, SPC, Sweden, United Kingdom, Validity

(Bristows)/ /2 Comments

Yesterday, 25 April 2018, AG Wathelet has handed down his opinion in the Teva v Gilead reference (Case C-121/17) suggesting that the question should be answered as follows: “The fact that a substance or combination of substances falls within the scope of protection of the basic patent is a necessary, but not sufficient, requirement for…

CJEU, European Union, Hungary, SPC

(Danubia Legal)/

Co-author: Zsolt Lengyel, Danubia Patent and Law Office Just before Christmas, on 20 December 2017, the Court of Justice of the European Union (CJEU) announced its judgment in C-492/16, Incyte, in a preliminary ruling proceeding initiated by the Budapest High Court. The decision can be considered a sequel to the CJEU’s earlier judgment C-471/15, Seattle…

European Union, Hungary, Unitary Patent, UPC

/

Concerns that inexperienced judges will do unpredictable or crazy things at the Unified Patent Court are exaggerated, according to Bird & Bird partner Wouter Pors. Last month he gave a lecture to future UPC judges at the Budapest Training Centre as part of a week of training on the issue of infringement. He wrote this…

Czech Republic, European Union, Finland, Hungary, Poland, UPC

/

Last week, we reported on the challenging endeavour to set up Patent Translate, the machine translation system which is under joint development by the European Patent Organisation (EPO) and Google and which is a crucial element of the Unitary Patent (UP) package. Intellectual Property Office (IPO) officials from Hungary, Finland and the Czech Republic told…

Czech Republic, European Union, Finland, Hungary, Poland, UPC

/ /1 Comment

For Europeans who don’t speak English, German or French, the three official Unitary Patent (UP) languages, the future UP system will bring about an even more radical change than for those that do. Over the years, millions of patents from companies all over the world will have been held valid in their territory, although these…

Case Law, Hungary, SPC

(Szecskay)/

Hungarian Supreme Court’s decision on conditions for granting supplementary protection certificates (SPC) under the transitional provisions of the Accession Treaty. The Supreme Court held that the first marketing authorization for the pharmaceutical product granted in any EU Member State (including the entire territory of the EU as enlarged due to the 2004 accessions, not restricted…